U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C16H19NO4
Molecular Weight 289.3264
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NORCOCAINE

SMILES

COC(=O)[C@@H]1[C@H]2CC[C@@H](C[C@@H]1OC(=O)C3=CC=CC=C3)N2

InChI

InChIKey=AYDBLCSLKNTEJL-RFQIPJPRSA-N
InChI=1S/C16H19NO4/c1-20-16(19)14-12-8-7-11(17-12)9-13(14)21-15(18)10-5-3-2-4-6-10/h2-6,11-14,17H,7-9H2,1H3/t11-,12+,13-,14+/m0/s1

HIDE SMILES / InChI

Molecular Formula C16H19NO4
Molecular Weight 289.3264
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
Development and validation of a gas chromatography/ion trap-mass spectrometry method for simultaneous quantification of cocaine and its metabolites benzoylecgonine and norcocaine: application to the study of cocaine metabolism in human primary cultured renal cells.
2010-11-15
Clinical physiology and mechanism of dizocilpine (MK-801): electron transfer, radicals, redox metabolites and bioactivity.
2010-08-19
Hair analysis for cocaine continues to be a valuable tool in forensic and clinical toxicology.
2010-07-29
Sensitive method for detection of cocaine and associated analytes by liquid chromatography-tandem mass spectrometry in urine.
2009-10
Cocaine modulates locomotion behavior in C. elegans.
2009-06-17
Simultaneous ultra-high-pressure liquid chromatography-tandem mass spectrometry determination of amphetamine and amphetamine-like stimulants, cocaine and its metabolites, and a cannabis metabolite in surface water and urban wastewater.
2009-04-10
A biomarker validation study of prenatal chlorpyrifos exposure within an inner-city cohort during pregnancy.
2009-04
Determination of cocaine and its metabolites using cation-selective exhaustive injection and sweeping-MEKC.
2008-11
A mechanism for the inhibition of neural progenitor cell proliferation by cocaine.
2008-06-10
Application of discriminant analysis to differentiate between incorporation of cocaine and its congeners into hair and contamination.
2008-03-21
Determination of cocaine, benzoylecgonine, cocaethylene and norcocaine in human hair using solid-phase extraction and liquid chromatography with tandem mass spectrometric detection.
2007-11-15
Bioanalytical procedures for determination of drugs of abuse in blood.
2007-08
Quantitative analysis of cocaine and its metabolites in whole blood and urine by high-performance liquid chromatography coupled with tandem mass spectrometry.
2007-06-01
Cocaine profiling for strategic intelligence purposes, a cross-border project between France and Switzerland. Part I. Optimisation and harmonisation of the profiling method.
2007-04-11
Application of a pyroprobe to simulate smoking and metabolic degradation of abused drugs through analytical pyrolysis.
2007-03
Therapeutic options and challenges for substances of abuse.
2007
Major and minor metabolites of cocaine in human plasma following controlled subcutaneous cocaine administration.
2006-10
External contamination of hair with cocaine: evaluation of external cocaine contamination and development of performance-testing materials.
2006-10
Determination of anatoxin-a in environmental water samples by solid-phase microextraction and gas chromatography-mass spectrometry.
2006-08
Validation of a method to detect cocaine and its metabolites in nails by gas chromatography-mass spectrometry.
2006-06-02
Simultaneous quantification of methamphetamine, cocaine, codeine, and metabolites in skin by positive chemical ionization gas chromatography-mass spectrometry.
2006-04-03
Simultaneous analyses of cocaine, cocaethylene, and their possible metabolic and pyrolytic products.
2006-02-10
Estrogen and progesterone affect cocaine pharmacokinetics in female rats.
2006-01-30
The quantitative analysis of heroin, methadone and their metabolites and the simultaneous detection of cocaine, acetylcodeine and their metabolites in human plasma by high-performance liquid chromatography coupled with tandem mass spectrometry.
2005-09-25
Dose-related distribution of codeine, cocaine, and metabolites into human hair following controlled oral codeine and subcutaneous cocaine administration.
2005-05
Gender differences in cocaine pharmacokinetics in CF-1 mice.
2005-01-15
Plasma butyrylcholinesterase activity protects against cocaine hepatotoxicity in female mice.
2005
Role of oxidative metabolites of cocaine in toxicity and addiction: oxidative stress and electron transfer.
2005
Levels of cocaine and its metabolites in washed hair of demonstrated cocaine users and workplace subjects.
2004-10-29
Effect of ketamine pretreatment on cocaine-mediated hepatotoxicity in rats.
2004-09-25
A fatal overdose of cocaine associated with coingestion of marijuana, buprenorphine, and fluoxetine. Body fluid and tissue distribution of cocaine and its metabolites determined by hydrophilic interaction chromatography-mass spectrometry(HILIC-MS).
2004-09
Determination of cocaine, its metabolites, pyrolysis products, and ethanol adducts in postmortem fluids and tissues using Zymark automated solid-phase extraction and gas chromatography-mass spectrometry.
2004-07-05
Sex differences in cocaine-induced behavioral responses, pharmacokinetics, and monoamine levels.
2004-04
Ecgonine methyl ester protects against cocaine lethality in mice.
2004
Effect of ketamine on cocaine-induced immunotoxicity in rats.
2003-10-14
Urine testing for cocaine abuse: metabolic and excretion patterns following different routes of administration and methods for detection of false-negative results.
2003-10
Detection and time course of cocaine N-oxide and other cocaine metabolites in human plasma by liquid chromatography/tandem mass spectrometry.
2003-08-15
Immunomodulation by cocaine and ketamine in postnatal rats.
2003-06-03
Immunosuppression and oxidative stress induced by acute and chronic exposure to cocaine in rat.
2003-04
Studies on metabolic pathways of cocaine and its metabolites using microsome preparations from rat organs.
2003-03
Reduction of tissue concentration of cocaine in rat by ketamine.
2003-02-14
Anti-cocaine vaccines: antibody protection against relapse.
2003-02
Toxic cocaine- and convulsant-induced modification of forced swimming behaviors and their interaction with ethanol: comparison with immobilization stress.
2002-11-09
Detection of cocaine analytes and opiates in nails from postmortem cases.
2002-10
Development and validation of a high-performance liquid chromatography method for the determination of cocaine, its metabolites and ketamine.
2002-03-29
Determination of the highest no-effect dose (HNED) and of the elimination pattern for cocaine in horses.
2002-03-29
The role of ketamine on plasma cocaine pharmacokinetics in rat.
2002-03-24
Lack of association between CYP2A5 induction and apoptosis in mouse primary hepatocytes.
2002-02-01
Human liver carboxylesterase hCE-1: binding specificity for cocaine, heroin, and their metabolites and analogs.
1997-09
Lethal toxicity from equimolar infusions of cocaine and cocaine metabolites in conscious and anesthetized rats.
1995-11
Patents

Patents

Substance Class Chemical
Created
by admin
on Mon Mar 31 18:00:32 GMT 2025
Edited
by admin
on Mon Mar 31 18:00:32 GMT 2025
Record UNII
3SL7BR2M1E
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NORCOCAINE
Common Name English
(-)-NORCOCAINE
Preferred Name English
8-AZABICYCLO(3.2.1)OCTANE-2-CARBOXYLIC ACID, 3-(BENZOYLOXY)-, METHYL ESTER, (1R,2R,3S,5S)-
Systematic Name English
N-DEMETHYLCOCAINE
Common Name English
METHYL (1R,2R,3S,5S)-3-(BENZOYLOXY)-8-AZABICYCLO(3.2.1)OCTANE-2-CARBOXYLATE
Systematic Name English
Code System Code Type Description
WIKIPEDIA
NORCOCAINE
Created by admin on Mon Mar 31 18:00:32 GMT 2025 , Edited by admin on Mon Mar 31 18:00:32 GMT 2025
PRIMARY
FDA UNII
3SL7BR2M1E
Created by admin on Mon Mar 31 18:00:32 GMT 2025 , Edited by admin on Mon Mar 31 18:00:32 GMT 2025
PRIMARY
MESH
C008671
Created by admin on Mon Mar 31 18:00:32 GMT 2025 , Edited by admin on Mon Mar 31 18:00:32 GMT 2025
PRIMARY
CAS
18717-72-1
Created by admin on Mon Mar 31 18:00:32 GMT 2025 , Edited by admin on Mon Mar 31 18:00:32 GMT 2025
PRIMARY
PUBCHEM
644007
Created by admin on Mon Mar 31 18:00:32 GMT 2025 , Edited by admin on Mon Mar 31 18:00:32 GMT 2025
PRIMARY
EPA CompTox
DTXSID80912319
Created by admin on Mon Mar 31 18:00:32 GMT 2025 , Edited by admin on Mon Mar 31 18:00:32 GMT 2025
PRIMARY